A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
Withdrawn before enrolling · Phase 1
Conditions studied: Hepatic Impairment
In brief
An oral dose of BMS-986141 administered in Hepatic Impairment and Healthy Participants to evaluate pharmacokinetics in this patient population.
Key facts
- Study ID
- NCT02985632
- Run by
- Bristol-Myers Squibb
- People needed
- 0
- Starts
- 2017-01-11
- Expected to finish
- 2017-07-07
- Last updated by the study team
- 2017-02-06
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Women not of childbearing potential (WNOCBP), and males, ages 18 to 70 years, inclusive.
- BMI of 20.0 to 38.0 kg/m2 inclusive
- Participants who a history of normal renal function
- Subjects with hepatic impairment must be on a stable dose of medication and/or treatment regimen
- Healthy subjects to the extent possible matched to four subjects with hepatic impairment with regard to body weight, age and gender, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
You may not qualify if…
- Any nonhepatic significant acute or chronic medical illness that could affect participant safety or data interpretation as determined by the investigator.
- History of recurrent dizziness or fall risk within 4 weeks of study drug administration
- History of primarily cholestatic liver diseases, autoimmune liver disease, metastatic liver disease or active alcoholic hepatitis
- History of known bleeding diathesis or coagulation disorder (eg, thrombotic thrombocytopenic purpura)
- Other protocol defined exclusion criteria could apply
Where it is running
- Clinical Pharmacology of Miami — Miami, Florida, United States
- Clinical Research Center — Orlando, Florida, United States
- Texas Liver Institute — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.